Clinical Trials Browser

OTHER × Prostate Cancer Metastatic × enzalutamide × Clear all

NCT02814968 2022-04-14

PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide

Phase 2 Completed

Prostate Cancer Metastatic

NCT02815033 2022-04-14

Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide

Phase 2 Completed

Prostate Cancer Metastatic